A new preclinical study by Mass Eye and Ear investigators showed ... from proliferative vitreoretinopathy (PVR) following a retinal detachment repair or traumatic injury to the eye.
WATERTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...